Phuturdex › Diseases › Complications of pregnancy
Drugs in development · updated 30 October 2026
Complications of pregnancy: drugs in development
As of 30 October 2026 there are 3 active clinical trials (recruiting or ongoing, phases I–III) on 3 drugs for complications of pregnancy. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| MetforminRiomet Er®, Glumetza® | III | 1 | NCT06452498 |
| AspirinVazalore®, Durlaza® | I–II | 1 | NCT06417411 |
| Certolizumab PegolCimzia® | II | 1 | NCT03152058 |
Sorted by most advanced phase and number of active trials.
All 3 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Premature Birth 31 drugs
- Pre-eclampsia 23 drugs
- Gestational diabetes 9 drugs
- Postpartum hemorrhage 4 drugs
- Bronchopulmonary dysplasia 11 drugs
- Hypertension, Pregnancy-Induced 7 drugs
- Fetal Growth Retardation 5 drugs
- Gestational trophoblastic disease 9 drugs
- Postpartum depression 9 drugs
- Arterial hypertension 119 drugs
- Stillbirth 5 drugs
- Type 2 diabetes 171 drugs
Broader categories
- Female urogenital diseases and pregnancy complications 3 drugs
- Urogenital Diseases 16 drugs
- Hypertension, Pregnancy-Induced 7 drugs
- Hematologic Diseases 57 drugs
- Genetic disease 33 drugs
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 4 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D011248 “Pregnancy Complications”.